Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation

Clinical trial NCT00399542 · COMPLETED

Trial details

NCT number: NCT00399542
Sponsor: Sucampo Pharma Americas, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Irritable Bowel Syndrome Constipation

Start date: 2005-05-01
Primary completion: 2006-07-01
Enrollment: 581

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.